Evidence map›Paper›PMID 38939644›Full record

ReviewJACC. Advances2024

Aortic Stenosis Management in Patients With Acute Hip Fracture.

Juan A Terré, Juan Torrado, Isaac George, Rafael Harari, Pedro R Cox-Alomar, Pedro A Villablanca, Robert T Faillace, Juan F Granada, George Dangas, Mario J Garcia and 2 more

Abstract readReview
In one paragraph

Review in JACC. Advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Juan A TerréSection of Cardiology, Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Juan TorradoDepartment of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
Isaac GeorgeStructural Heart and Valve Center, New York Presbyterian Hospital, Columbia University Medical Center, New York, New York, USA.
Rafael HarariDepartment of Cardiology, Bellevue Hospital, New York, New York, USA.
Pedro R Cox-AlomarDepartment of Cardiology, Louisiana State University, New Orleans, Louisiana, USA.
Pedro A VillablancaDepartment of Cardiology, Henry Ford Medical Center, Detroit, Michigan, USA.
Robert T FaillaceDepartment of Medicine, Jacobi Medical Center/North Central Bronx Hospital, Bronx, New York, USA.
Juan F GranadaCardiovascular Research Foundation, New York, New York, USA.
George DangasDepartment of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Mario J GarciaDepartment of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
Azeem LatibDepartment of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
José WileySection of Cardiology, Department of Medicine, Tulane University, New Orleans, Louisiana, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of severe aortic stenosis (SAS) has evolved rapidly with the advent of minimally invasive structural heart interventions. Transcatheter aortic valve replacement has allowed patients to undergo definitive SAS treatment achieving faster recovery rates compared to valve surgery. Not infrequently, patients are admitted/diagnosed with SAS after a fall associated with a hip fracture (HFx). While urgent orthopedic surgery is key to reduce disability and mortality, untreated SAS increases the perioperative risk and precludes physical recovery. There is no consensus on what the best strategy is either hip correction under hemodynamic monitoring followed by valve replacement or preoperative balloon aortic valvuloplasty to allow HFx surgery followed by valve replacement. However, preoperative minimalist transcatheter aortic valve replacement may represent an attractive strategy for selected patients. We provide a management pathway that emphasizes an early multidisciplinary approach to optimize time for hip surgery to improve orthopedic and cardiovascular outcomes in patients presenting with HFx-SAS.

Indexed as

aortic stenosisballoon aortic valvuloplastyhip fracturehip fracture surgeryHOSmanagementminimalist transcatheter aortic valve replacementnon cardiac surgeryprotocolSAVRTAVRtranscatheter aortic valve replacementtreatment algorithm

Identifiers

PMID38939644
PMCPMC11198465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.